CA Patent

CA2704943A1 — Compositions for the treatment of gastrointestinal inflammation

Assigned to Meritage Pharma Inc · Expires 2009-05-22 · 17y expired

What this patent protects

Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract for example those involving the esophagus Also provided herein

USPTO Abstract

Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract for example those involving the esophagus Also provided herein

Drugs covered by this patent

Patent Metadata

Patent number
CA2704943A1
Jurisdiction
CA
Classification
—
Expires
2009-05-22
Drug substance claim
No
Drug product claim
No
Assignee
Meritage Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.